PL349955A1 - Radioactive cisplatin in the treatment of cancer - Google Patents

Radioactive cisplatin in the treatment of cancer

Info

Publication number
PL349955A1
PL349955A1 PL00349955A PL34995500A PL349955A1 PL 349955 A1 PL349955 A1 PL 349955A1 PL 00349955 A PL00349955 A PL 00349955A PL 34995500 A PL34995500 A PL 34995500A PL 349955 A1 PL349955 A1 PL 349955A1
Authority
PL
Poland
Prior art keywords
cancer
treatment
cisplatin
radioactive
radioactive cisplatin
Prior art date
Application number
PL00349955A
Inventor
Stanley E Order
Original Assignee
Isotope Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isotope Solutions filed Critical Isotope Solutions
Priority to PL00349955A priority Critical patent/PL349955A1/en
Priority claimed from PCT/US2000/006546 external-priority patent/WO2000056369A1/en
Publication of PL349955A1 publication Critical patent/PL349955A1/en

Links

PL00349955A 2000-03-14 2000-03-14 Radioactive cisplatin in the treatment of cancer PL349955A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL00349955A PL349955A1 (en) 2000-03-14 2000-03-14 Radioactive cisplatin in the treatment of cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2000/006546 WO2000056369A1 (en) 1999-03-19 2000-03-14 Radioactive cisplatin in the treatment of cancer
PL00349955A PL349955A1 (en) 2000-03-14 2000-03-14 Radioactive cisplatin in the treatment of cancer

Publications (1)

Publication Number Publication Date
PL349955A1 true PL349955A1 (en) 2002-10-21

Family

ID=20079540

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00349955A PL349955A1 (en) 2000-03-14 2000-03-14 Radioactive cisplatin in the treatment of cancer

Country Status (1)

Country Link
PL (1) PL349955A1 (en)

Similar Documents

Publication Publication Date Title
EP1311262A4 (en) Cancer treatment by combination therapy
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
IL158273A0 (en) Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
GB0016787D0 (en) Compounds useful in therapy
AU2003212634A8 (en) Compounds useful in the treatment of cancer
HUP0300339A3 (en) Use of fulvestrant in the treatment of resistant breast cancer
EP1349485A4 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
HUP0200717A3 (en) Radioactive cisplatin in the treatment of cancer
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
IL161762A0 (en) Estradiol inhibiting agents in breast cancer
SG112006A1 (en) Radioactive arsenic-containing compounds and their uses in the treatment of tumors
GB0026015D0 (en) Cancer treatment
HK1058623A1 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer.
EP1259255A4 (en) Pai-2 conjugates for the treatment and imaging of cancer
PL349955A1 (en) Radioactive cisplatin in the treatment of cancer
GB9804361D0 (en) Cancer treatment
EP1463511A4 (en) Combination cancer therapy
GB0014046D0 (en) Compounds useful in therapy
GB0027780D0 (en) Treating cancer
GB0017620D0 (en) Flavonoids in cancer treatment
SI1272195T1 (en) Use of fulvestrant in the treatment of resistant breast cancer
GB0021508D0 (en) Cancer treatment and prognosis
GB0018587D0 (en) Cancer treatment and prognosis

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)